A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Altamira Therapeutics Ltd’s current trading price is -95.08% away from its 52-week high, while its distance from the 52-week low is 59.01%. The stock’s price range for this time frame has been between $1.61 and $52.00. The trading volume of the company’s shares in the Healthcare reached around 51.78 million for the day, which was evidently higher than the average daily volume of 0.19 million over the last three months.
The market performance of Altamira Therapeutics Ltd has been somewhat unstable. Over the past year, the company’s stock achieved a high of $52.00 on 04/12/23, with the lowest value for the same timeframe being $1.61, recorded on 02/07/24.
How Financial Performance Impacts Market Capitalization
Altamira Therapeutics Ltd (CYTO) has experienced a quarterly decline of -22.66% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 4.04M and boasts a workforce of 18 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.1414, with a change in price of -0.4787. Similarly, Altamira Therapeutics Ltd recorded 1,147,885 in trading volume during the last 100 days, posting a change of -15.65%.
CYTO Stock Stochastic Average
The raw stochastic average for Altamira Therapeutics Ltd over the last 50 days is presently at 51.56%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 51.30%. Further, the company’s Stochastic %K and %D values for the last 20 days were 22.16% and 11.65%, respectively.
CYTO Stock Price Performance Analysis
The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The index has shown a price loss of -26.44% this year. Over the last six months, there has been a stronger performance of -47.56%. The price of CYTO fallen by 42.22% during the last 30 days period. For the last 5-days stocks have improved 51.48%.
